Oligonucleotide Synthesis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Oligonucleotide Synthesis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Custom Oligonucleotide Segment Leads with Strong Market Share and Robust Growth Prospects

Oligonucleotides, short fragments of nucleic acids, are witnessing a significant surge in demand as they play a pivotal role in laboratories for various applications including therapeutics, diagnostics, academic research, and industrial processes. These molecules, synthesized through a combination of genetic engineering and enzyme chemistry, have become indispensable in the realms of initial research, target validation, and drug production.

Oligonucleotide synthesis can occur either through commercial services catering to a wide range of end users or through individual synthesis using DNA synthesizers. Recent advancements in synthesis techniques, amplification methods, and automation have revolutionized biological research, offering researchers the ability to customize and obtain specific sequences conveniently and promptly. These services vary in terms of cost per base pair, error rates, lengths, and throughput, among other factors.

Market Analysis Highlights:

According to market analysis, the custom oligonucleotide synthesis segment is expected to lead the market with a higher market share compared to the universal oligonucleotide synthesis segment. The custom oligonucleotide segment is projected to reach a market size of over US$ 540 million by the end of 2025. Meanwhile, the universal oligonucleotide synthesis segment is anticipated to expand at a CAGR of 7.8% during the forecast period from 2024 to 2031.

In light of these growth prospects, companies are intensifying their focus on improving services through technological enhancements, enabling high-throughput synthesis while maintaining cost-effectiveness to capture maximum market share.

Key Drivers of the Oligonucleotide Synthesis Market:

The global market for custom oligonucleotide synthesis is experiencing rapid growth, fueled by the increasing pace of research and development in synthetic biology. The industry's demand for high-end customized oligos is on the rise, particularly as synthetic oligonucleotides find applications in various industrial and academic research labs. This surge in demand is driving efforts to enhance quality by reducing impurities and increasing effectiveness.

Challenges posed by the cost of purification, which accounts for approximately 50% of total production costs, are prompting ongoing research to identify improved methods for achieving desired results. Innovative non-chromatographic purification methods and in-house modifications are among the avenues explored to overcome this hurdle.

Market Dynamics:

The global oligonucleotide synthesis market is currently characterized by established players in both equipment and services, boasting strong brand recognition and extensive distribution channels. These systematic distribution networks have contributed to the market's upward trajectory.

However, a noteworthy trend has emerged with the in-house development of oligonucleotides, primarily driven by academic and research institutes. Some biopharmaceutical companies have also opted to develop oligonucleotides in-house or outsource the manufacturing process to maintain confidentiality and streamline production. This trend, although beneficial for cost efficiency, may impact sales from service providers and potentially narrow the market scope.

Challenges in the Oligonucleotide Synthesis Market:

Despite the promising growth outlook, the global oligonucleotide synthesis market faces certain challenges. In-house development by academic and research institutes, coupled with cost constraints, could restrict the market's scope. Additionally, limitations in available resources, including funding for research in academic laboratories and a shortage of skilled personnel, may hinder research activities and, consequently, the market's growth.

Market Segmentation

By Service Type
• Universal Oligonucleotide Synthesis
• Custom Oligonucleotide Synthesis

By Application
• Academic R&D
• Commercial R&D

By End Users
• Biopharmaceutical Companies
• Academic & Research Institutes
• Contract Research Organizations

By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.